1. Pharmacological properties of AR-C 239, a new alpha-adrenoreceptor blocking drug;Mouille;J. Cardiovasc Pharmacol,1980
2. Role of alpha1 and alpha2 adrenoreceptors in the modulation of the baroflex vagal bradycardia;Huchet;Eur J Pharmacol,1981
3. AR-C 239;Sneddon;Drugs of the Future,1981
4. Hemodynamic effects of intravenous administration of a new alpha1 antagonist drug AR-C 239 in patients with left heart failure (abstr);Colle;Eur Heart J,1985
5. beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure;Feldman;Am Heart J,1981